產(chǎn)品搜索
相關(guān)文章
- 一起認(rèn)識(shí)下腫瘤細(xì)胞的遷移性
- TROP2靶點(diǎn)藥物爆發(fā),診斷質(zhì)控緊跟步伐--科佰TROP2 IHC質(zhì)控品上新
- 實(shí)驗(yàn)?zāi)芊裰貜?fù)仍在持續(xù):誰(shuí)來(lái)給韓春雨事件畫上句號(hào)?
- 抑制性檢查點(diǎn)靶點(diǎn)及其細(xì)胞篩選模型
- 腫瘤細(xì)胞的四大原代培養(yǎng)方法闡述
- 科學(xué)家如何深度破解癌癥基因組的奧秘?
- 41BB——T細(xì)胞共刺激新靶點(diǎn)
- BRAF系列標(biāo)準(zhǔn)品
- 拯救偏頭痛!CGRP及其受體拮抗劑研究進(jìn)展
- 【連載-企業(yè)參考品】胃腸道間質(zhì)瘤的PCR和NGS參考品的選擇
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73218EGFR D770_N771insY/BaF3
- 詳細(xì)內(nèi)容
| CBP73218 | |
| I. Introduction | |
Cell Line Name: | EGFR D770_N771insY/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
EGFR D770_N771insY results in the insertion of a tyrosine (Y) in the protein kinase domain of the Egfr protein between amino acids 770 and 771 (UniProt.org). D770_N771insY has not been biochemically characterized, but is predicted to result in a gain of function based on the effect of other Egfr exon 20 insertions (PMID: 24353160). | |
| III. Representative Data | |
1. WB of EGFR D770_N771insY/BaF3
| |
| 2. Anti-proliferation assay | |




會(huì)員_a.png)